↓ Skip to main content

Cochrane Database of Systematic Reviews

Duloxetine for treating painful neuropathy or chronic pain

Overview of attention for article published in this source, October 2009
Altmetric Badge

Mentioned by

1 policy source
4 tweeters
1 Facebook page


149 Dimensions

Readers on

83 Mendeley
Duloxetine for treating painful neuropathy or chronic pain
Published by
John Wiley & Sons, Ltd, October 2009
DOI 10.1002/14651858.cd007115.pub2
Pubmed ID

Lunn, Michael PT, Hughes, Richard AC, Wiffen, Philip J


Duloxetine is a balanced serotonin and noradrenaline reuptake inhibitor licensed for the treatment of major depressive disorders, urinary stress incontinence and the management of neuropathic pain associated with diabetic peripheral neuropathy. A number of trials have been conducted to investigate the use of duloxetine in neuropathic and nociceptive painful conditions.

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 83 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 2%
United States 2 2%
Spain 1 1%
Hong Kong 1 1%
Unknown 77 93%

Demographic breakdown

Readers by professional status Count As %
Student > Master 13 16%
Researcher 13 16%
Student > Postgraduate 10 12%
Student > Ph. D. Student 9 11%
Other 8 10%
Other 15 18%
Unknown 15 18%
Readers by discipline Count As %
Medicine and Dentistry 30 36%
Psychology 10 12%
Nursing and Health Professions 6 7%
Chemistry 4 5%
Agricultural and Biological Sciences 4 5%
Other 11 13%
Unknown 18 22%